Helping Spanish-speaking patients manage high-risk drinking days with mobile treatment
Targeting High Risk Drinking Days with Mobile Treatment for Spanish-Speaking Patients
This study is creating a helpful mobile program for Spanish-speaking people who want to cut back on drinking, offering support right when they need it most, using easy-to-understand techniques that fit their culture.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10896435 on NIH RePORTER |
What this research studies
This research aims to develop a mobile treatment program specifically designed for Spanish-speaking individuals who struggle with high-risk drinking days. By utilizing culturally adapted cognitive behavioral therapy (CBT) techniques delivered through mobile technology, the program seeks to provide immediate support during critical moments when individuals may be tempted to drink excessively. The approach focuses on overcoming barriers to treatment access, such as language and cultural differences, to improve outcomes for this underserved population. Participants will engage with the program during peak drinking times, allowing for timely intervention and support.
Who could benefit from this research
Good fit: Ideal candidates for this research are Spanish-speaking individuals aged 21 and older who experience high-risk drinking behaviors.
Not a fit: Patients who do not speak Spanish or who do not engage in high-risk drinking behaviors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce harmful alcohol consumption among Spanish-speaking patients by providing accessible and culturally relevant treatment options.
How similar studies have performed: Previous studies have shown success with similar mobile treatment approaches for substance use disorders, particularly in English-speaking populations, indicating potential for effectiveness in Spanish-speaking communities as well.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Benitez, Bryan — Yale University
- Study coordinator: Benitez, Bryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.